-
May Pharmaceutical Executive Moves Summary
According to reliable industry sources, several high-profile pharmaceutical companies experienced significant leadership changes in May.
2024-06-11 16:53 -
Ipsen and Marengo Expand Collaboration to Explore New Frontiers in Tumor Immunotherapy
Recently, international pharmaceutical company Ipsen announced that it will further expand its existing collaboration with Marengo Therapeutics, a sta...
2024-06-11 16:51 -
The Treatment of Gastric Cancer Has Witnessed A Remarkable New Breakthrough
Recent advances in gastric cancer treatment, despite the increasing number of treatment options for advanced gastric cancer, have not yet led to signi...
2024-06-11 16:50 -
Chinese Biopharmaceutical CompanyHenlius Expands to Middle East Market with Launch of Biosimilar Dru...
In a significant milestone, the Chinese biopharmaceutical company Henlius (Henlius) has announced the shipment of its self-developed and manufactured ...
2024-06-07 17:29 -
Merck Bets Big on AI-Powered Drug Development with $376 Million Deal
In a move to bolster its drug discovery efforts, German pharmaceutical giant Merck KGaA has announced a major collaboration with Israeli biotech compa...
2024-06-07 17:24 -
Nvidia Invests in Another AI Pharmaceutical Startup, Vilya
In a move that further solidifies its commitment to the AI pharmaceutical space, Nvidia has participated in a $71 million Series A funding round for t...
2024-06-07 17:23 -
Alphamab Oncology and Arrivent Collaborate on Over $600 Million ADC Drug Development
Alphamab Oncology announced a research and commercialization partnership with ArriVent BioPharma, Inc. to discover and develop new antibody-drug conju...
2024-06-06 17:30 -
Breakthrough in Metastatic Breast Cancer Treatment: Trastuzumab Deruxtecan Shows Impressive 13.2-Mon...
The phase 3 DESTINY-Breast06 trial has revealed that the antibody-drug conjugate trastuzumab deruxtecan (marketed as Enhertu) significantly improves p...
2024-06-05 17:28 -
Zelgen Biopharmaceuticals Submits BLA for Innovative rhTSH Product
Zelgen Biopharmaceuticals has announced the submission of a Biologics License Application (BLA) to the National Medical Products Administration (NMPA)...
2024-06-05 17:26 -
Merck's Chief Medical Officer's Perspective on AK112
On May 31st, Akeso Biopharma announced that the results of the HARMONi-2 study for AK112 (ivosidenib) exceeded expectations - the AK112 treatment grou...
2024-06-05 17:21
Hot News
- BASF’s Big Restructuring: Cut... Sep 01, 2025
- German Chemical Industry Outpu... Sep 15, 2025
- DuPont Bids Farewell to Its Ar... Sep 02, 2025
- ExxonMobil Eyes $1 Billion Pet... Sep 16, 2025
- FDA Clears Sanofi’s Wayrilz (... Aug 31, 2025
Related Products
Related Producers
